Telemedicine services are being adopted widely by healthcare providers during the COVID-19 pandemic to continue providing services and avoid further surge in infection rate. Policy barriers around use of telemedicine were also quickly lifted increasing its adoption. Telemedicine is expected to remain a vital part of the health visits post COVID-19.

Verdict has conducted a poll to assess whether reimbursement of telemedicine services will continue once the COVID-19 pandemic is abated.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Analysis of the results shows that the reimbursement is expected to continue after the COVID-19 pandemic abatement.

A majority of 72% of the respondents expressed confidence about the reimbursement, while the remaining 28% opined otherwise.Telemedicine reimbursement

The analysis is based on 368 responses received from the readers of Verdict’s Pharmaceutical Technology site between 18 June and 20 July.

Healthcare spending to shift towards telemedicine

Consumers of telemedicine services in the US increased to 46% compared to 11% before the COVID-19 pandemic, according to a report from McKinsey and Company, which notes that approximately $250bn in US healthcare spending is expected to shift towards telemedicine after the pandemic ends.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Effectiveness compared to in-person visits, security, and reimbursement continues to remain crucial in the future success of telemedicine services. Physicians and doctors have upheld the importance of telemedicine services even with institutions such as the American College of Rheumatology (ACR) supporting its continued use.

The ACR also supported continued reimbursement of virtual visits. The Centers for Medicare and Medicaid Services (CMS) was quick to include reimbursements for telemedicine services amid the pandemic. As consumers become more comfortable with using telemedicine services, incorporating more changes to reimbursement policies will help in increased adoption.

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now